Palmitoylation of EGFR alters its cellular distribution and is crucial for growth of TKI‐resistant EGFR mutated NSCLC cells Palmitoylation of EGFR alters.

Slides:



Advertisements
Similar presentations
Supplemental Figure S2. Location and H 2 O 2 -dependent binding of RBPs to biotinylated MKP-1 transcripts. (A) Schematic of the MKP-1 mRNA showing the.
Advertisements

Loss of Hdac3 impairs Ar signaling in mouse prostate tissues and has no effect on apoptosis Loss of Hdac3 impairs Ar signaling in mouse prostate tissues.
Network protein vulnerability in EGFR TKI‐resistant cells and specific for EGFR‐mutated cells. Network protein vulnerability in EGFR TKI‐resistant cells.
Caspase‐2 activation is a prerequisite for TRAIL‐mediated apoptosis.
The N‐terminus and SH2 domain of SOCS‐1 contribute to inhibition of JAK1 and JAK2 kinase activity. The N‐terminus and SH2 domain of SOCS‐1 contribute to.
Full‐length XIAPs that retain caspase 9 inhibitory potential inhibit UV‐induced cell death. Full‐length XIAPs that retain caspase 9 inhibitory potential.
Nuclear Akt is required for the antiapoptotic action of NGF
PKCK2 determines TRAIL sensitivity.
Wild‐type p53 binds and represses Rad51 promoter.
FOXP3 regulates cAMP production by regulating miR‐142‐3p and AC9.
GLUT3 is a direct target of TCF4/β‐catenin
The HDAC3 inhibitor suppresses SPOP‐mutated prostate cancer cell growth The HDAC3 inhibitor suppresses SPOP‐mutated prostate cancer cell growth A22Rv1.
Interaction with Snail1 is required for LSD1 recruitment to the E‐cadherin promoter in vivo. Interaction with Snail1 is required for LSD1 recruitment to.
Interactions between Aiolos and Ikaros proteins are detected within the cell nucleus. Interactions between Aiolos and Ikaros proteins are detected within.
by Wu-Guo Deng, Ying Zhu, and Kenneth K. Wu
AAV8‐hAAT‐FGF21 treatment improves liver fibrosis
The scaffold protein APPL1 facilitates HDAC3 regulation of AKT
a b MCF-7 TR2 MCF-7 TR2 (Fold change) MTT Assay , (Fold change)
ADAM8 maintains the aggressive phenotype of TNBC cells in 3D‐culture A–DCells were transfected with siRNAs as in Fig 2D and E for 24 h, and tested for.
MiR‐199a directly targets ERBB2 and ERBB3, whereas miR‐125b targets ERBB3. miR‐199a directly targets ERBB2 and ERBB3, whereas miR‐125b targets ERBB3. (A)
The MSP domain of MOSPD2 is sufficient to interact with STARD3 and STARD3NL The MSP domain of MOSPD2 is sufficient to interact with STARD3 and STARD3NL.
Mitochondrial HMGB1 is linked to mitochondrial functions Western blot with separated cellular components from the cerebellar tissues of the three genotypes.
Drug network derived from the core EGFR interactome and combination strategy to overcome the resistant cells. Drug network derived from the core EGFR interactome.
Characterization of oligo#5 and its derivatives
SEMA3C silencing inhibits CRPC cell growth and induces apoptosis
Inhibition of CDK6 kinase activity sensitizes EOC cells to platinum in vitro Inhibition of CDK6 kinase activity sensitizes EOC cells to platinum in vitro.
Nuclear export of endogenous APC in different cell lines.
Transcription Factor MIZ-1 Is Regulated via Microtubule Association
Hdac3 deletion decreases AKT phosphorylation and tumor growth in Pten knockout prostate cancer Hdac3 deletion decreases AKT phosphorylation and tumor growth.
HMGB1 reverses mitochondrial DNA damage caused by mutant Atxn1 The mitochondrial DNA amplification assay with cerebellar tissue revealed that mitochondrial.
Schematic diagram of the proposed model depicting the functional relationship between EGFR and FASN in TKI resistance within EGFR mutant NSCLC cells Schematic.
Akt inhibition with AZD5363 does not enhance the radiosensitivity of tumour cells in vitro Akt inhibition with AZD5363 does not enhance the radiosensitivity.
EGFR is intrinsically active in FGFR3-activated cell lines with combination efficacy from targeting both EGFR and FGFR3. EGFR is intrinsically active in.
The mutant ZIP13 protein is degraded through a VCP‐dependent mechanism Identification of VCP/Cdc48/p97 as a ZIP13‐associating protein. The mutant ZIP13.
T55delinsRT mutation in MEK1 is responsible for resistance to vemurafenib in M032R4 Somatic mutations present in each of these metastases, revealing that.
The SREBP Pathway in Drosophila
Volume 85, Issue 7, Pages (June 1996)
Surface biotinylation and fate of TREM2
Enhancement of receptor endocytosis, as well as cellular apoptosis, may explain the cooperative anti‐tumor actions of 3×mAbs and osimertinib Enhancement.
HPV‐E7 targets RB for induction of ceramide‐dependent mitophagy
miR‐34a‐5p acts in PDGFRα+ cells to block lung alveolarization
Volume 10, Issue 2, Pages (January 2015)
Knock‐in mutation of the T1348N mutation that ablates GTP binding to LRRK2 abolishes Rab10 and biomarker phosphorylation Knock‐in mutation of the T1348N.
C266S laforin's effect on LD‐associated general defect in autophagy
Effect of memantine on Klk7‐dependent Aβ degradation activity
STARD3‐mediated cholesterol accumulation in endosomes does not alter cholesterol homeostasis STARD3‐mediated cholesterol accumulation in endosomes does.
Oligo#5 influences the ratio of the two serotonin 2C receptor isoforms and changes the localization of the full‐length receptor Oligo#5 influences the.
Both E102Q and L95fs Sig1R variants are unstable and lose their abilities to control Ca2+ flux in Neuro2a cells Both E102Q and L95fs Sig1R variants are.
The CHCH domain is necessary for mitochondrial import of CHCHD10
Growth of TKI‐resistant EGFR delE746‐A750 PC‐9 NSCLC cells is associated with elevated cellular free fatty acid and expression of FASN, and is suppressed.
Activation of Drp1 by E2F5‐Drp1 complex enhances HPV‐E7/ceramide‐mediated lethal mitophagy Activation of Drp1 by E2F5‐Drp1 complex enhances HPV‐E7/ceramide‐mediated.
Cell viability assay in NSCLC cell lines in response to gefitinib and Taxol. Cell viability assay in NSCLC cell lines in response to gefitinib and Taxol.
Generation of doxycycline‐inducible SW620:GPRC5Asi1R cells and optimisation of flow cytometry for use in violet ratiometric membrane asymmetry apoptosis.
PRG‐1R346T: loss‐of‐function mutation reduced LPA internalization due to altered O‐glycosylation PRG‐1R346T: loss‐of‐function mutation reduced LPA internalization.
The oligoclonal antibody overcomes the C797S mutation‐mediated resistance to osimertinib The oligoclonal antibody overcomes the C797S mutation‐mediated.
Shrestha Ghosh, Baohua Liu, Yi Wang, Quan Hao, Zhongjun Zhou 
Volume 10, Issue 2, Pages (August 2002)
PARP cleavage is detected in TA cells, but not in KSC
Knocking down Wnt3 increases the cells' response to trastuzumab and reduces cells' invasiveness. Knocking down Wnt3 increases the cells' response to trastuzumab.
RXRa serves as a carrier for TR3 translocation initiated by 9-cis retinoic acid. RXRa serves as a carrier for TR3 translocation initiated by 9-cis retinoic.
JAK3A572V mutation causes constitutive JAK3 activity and IL-2–independent proliferation of NKTCL cells. JAK3A572V mutation causes constitutive JAK3 activity.
Volume 9, Issue 1, Pages (January 2002)
LAT Palmitoylation Immunity
The role of p53 in H2O2-mediated cell death of hOGG1-deficient H1299 lung carcinoma p53 null cells. The role of p53 in H2O2-mediated cell death of hOGG1-deficient.
N-Terminal Palmitoylation of PSD-95 Regulates Association with Cell Membranes and Interaction with K+ Channel Kv1.4  J.Rick Topinka, David S Bredt  Neuron 
Localization of oxidated thiols in A375 melanoma cells.
AS1411 alters subcellular distribution of PRMT5 in a time-dependent, dose-dependent, and nucleolin-dependent manner. AS1411 alters subcellular distribution.
Jörg Hartkamp, Brian Carpenter, Stefan G.E. Roberts  Molecular Cell 
Effect of bevacizumab on the proliferation of A2780 cells.
Effects of NMT siRNAs on MARCKS and c-Src.
Presentation transcript:

Palmitoylation of EGFR alters its cellular distribution and is crucial for growth of TKI‐resistant EGFR mutated NSCLC cells Palmitoylation of EGFR alters its cellular distribution and is crucial for growth of TKI‐resistant EGFR mutated NSCLC cells Western blot analysis showing EGFR palmitoylation levels in PC‐9P, PC‐9GR, H1975, and NL20 cells treated with Gefitinib for 72 h. Hydroxylamine (HAM) is a strong reducing agent that cleaves palmitate from cysteine residues and is necessary for biotinylation. The omission of HAM cleavage (HAM‐) serves as negative control for ABE assay.Western blot data showing EGFR palmitoylation in cells treated with either scrambled, EGFRi#1, EGFRi#1 plus tGFP‐tagged EGFR mutant combination, or EGFRi#1 plus tGFP‐tagged EGFR wild‐type for 72 h. tGFP‐tagged EGFR is about 197 kDa, while EGFR is 170 kDa.Western blot analysis showing palmitoylation of mutated EGFR under cell‐free conditions. Cell‐free synthesized tGFP‐tagged EGFR was generated by in vitro translation using vectors containing EGFR wild‐type or mutants (del746‐750 or L858R/T790M), with no DNA/template as negative control. Fresh extracts of PC‐9GR, H1975 and H1703 cells were prepared in hypotonic buffer. For in vitro palmitoylation, synthesized tGFP‐tagged EGFR was incubated in cell extracts for 1 h at 37°C, followed by ABE assay and Western blotting.Vehicle‐ and 2‐bromopalmitic acid (50 μM of 2‐BP)‐treated cells were harvested and cellular fractionation was carried out to obtain nuclear, cytosolic, and membrane fractions and a part of these fractions were analyzed by Western blotting to detect EGFR. The remaining fractions were subjected to EGFR pulldown by anti‐EGFR antibody and in vitro ABE assay. Palmitoylation of EGFR was then determined by Western blot analysis.Cell viability assays (n = 3) of cells were first treated with 250 μM of 2‐BP for 24 h, followed by the supplementation of 10 μM of palmitate and a further incubation for 48 h. Significance in differences in viability index, in which 2‐BP‐treated cells acted as controls, was determined by t‐test. Error bars denote SEM.Growth curves (n = 3) illustrating the proliferation index of cells treated with scrambled, EGFR siRNAs (EGFRi#1) alone or in combination with transfection of tGFP‐tagged EGFR mutant (del746‐750 or L858R/T790M) constructs with or without C797A/C1049A/C1146A mutations for 72 h. Significance in differences in proliferation index, in which EGFRi#1 cells acted as controls, was determined by t‐test. Error bars denote SEM.Cells were transfected with tGFP‐tagged EGFR mutant (del746‐750 or L858R/T790M) constructs with or without C797A/C1049A/C1146A mutations and harvested after 72 h. Cellular fractionation was performed to separate nuclear, cytosolic, and membrane fractions. Fractionates were then analyzed by Western blot analysis to detect the distribution of tGFP‐tagged EGFR with anti‐tGFP antibody. Source data are available online for this figure. Azhar Ali et al. EMBO Mol Med. 2018;emmm.201708313 © as stated in the article, figure or figure legend